| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.07. | Venus Concept Inc.: Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada | 289 | GlobeNewswire (Europe) | TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution... ► Artikel lesen | |
| 13.05. | Venus Concept Inc.: Venus Concept Announces Senior Management Changes | 206 | GlobeNewswire (Europe) | TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced changes to its senior leadership team.... ► Artikel lesen | |
| 01.04. | Venus Concept Inc.: Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger | 218 | GlobeNewswire (Europe) | TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced the successful completion by affiliates... ► Artikel lesen | |
| VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
| 21.01. | Venus Concept Inc.: Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC | 263 | GlobeNewswire (Europe) | TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market... ► Artikel lesen | |
| 13.11.25 | Venus Concept Inc.: Venus Concept Announces Third Quarter 2025 Financial Results | 499 | GlobeNewswire (Europe) | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
| 10.11.25 | Venus Concept Inc.: Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments | 400 | GlobeNewswire (Europe) | TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance... ► Artikel lesen | |
| 02.10.25 | Venus Concept Inc.: Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction | 346 | GlobeNewswire (Europe) | TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,905 | -0,51 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,950 | -2,70 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,260 | +1,91 % | Eckert&Ziegler-Aktie im Check am 17.09. (08:16 Uhr): Meine aktuelle Lageeinschätzung | ||
| UNITEDHEALTH | 328,20 | +0,31 % | Dividendenbekanntmachungen (14.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BROOKFIELD CORPORATION CA11271J1075 0,07 USD 0,0603 EUR BROOKFIELD WEALTH SOLUTIONS LTD BMG174341047 0,07 USD 0,0603 EUR CALAMOS... ► Artikel lesen | |
| THERMO FISHER | 572,80 | +1,31 % | Dividendenbekanntmachungen (15.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| TELADOC HEALTH | 5,614 | +0,07 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,160 | -1,06 % | HIMS Bulls Should Heed This Historic Chart Signal | ||
| BICO GROUP | 2,010 | +6,35 % | BICO Group AB: Publication of BICO Group AB: Interim Report Q2 2026 | Improved profitability and AI advancements
"In the quarter we had a continued solid momentum with growth in our bench top instruments and consumables businesses, while still experiencing challenges... ► Artikel lesen | |
| CERENOME | 1,756 | -0,34 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| RESMED | 201,60 | +1,28 % | CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded | ||
| HEALWELL AI | 0,465 | +1,53 % | HEALWELL AI: HEALWELL's DARWEN AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research | New research accepted for presentation at AMIA 2026 demonstrates the performance of HEALWELL's DARWEN AI-powered SMARTSuite, including clinical summarization results that outperformed published benchmarks... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,140 | +1,90 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| HENRY SCHEIN | 73,50 | -3,29 % | Henry Schein Inc. Profit Advances In Q2 | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $94 million, or $0.82 per share. This... ► Artikel lesen | |
| AETHLON MEDICAL | 7,020 | +390,91 % | Morning Market Movers: Aethlon Medical, CID HoldCo, Longeveron, Delixy See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 9,240 | +6,08 % | Alignment Healthcare extends retreat, falls an additional 16% |